Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-02-21

Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of ENN0403 for diabetic macular edema is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENN0403

Snippet

Sponsor: EnnovaBio | Conditions: Diabetic Macular Edema (DME) | Phase 2 | Status: RECRUITING